These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 31624299)

  • 21. Tissue inhibitor of metalloproteinases-3 transfer suppresses malignant behaviors of colorectal cancer cells.
    Lin H; Zhang Y; Wang H; Xu D; Meng X; Shao Y; Lin C; Ye Y; Qian H; Wang S
    Cancer Gene Ther; 2012 Dec; 19(12):845-51. PubMed ID: 23037807
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aberrant methylation-mediated silencing of lncRNA CTC-276P9.1 is associated with malignant progression of esophageal squamous cell carcinoma.
    Guo W; Liu S; Dong Z; Guo Y; Ding C; Shen S; Liang J; Shan B
    Clin Exp Metastasis; 2018 Feb; 35(1-2):53-68. PubMed ID: 29524086
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of TIMP3 expression with vessel density, macrophage infiltration and prognosis in human malignant melanoma.
    Das AM; Koljenović S; Oude Ophuis CM; van der Klok T; Galjart B; Nigg AL; van Cappellen WA; Noordhoek Hegt V; Dinjens WN; Atmodimedjo PN; Vermeulen CE; Verhoef C; Eggermont AM; ten Hagen TL
    Eur J Cancer; 2016 Jan; 53():135-43. PubMed ID: 26707830
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Smad2/3/4 Pathway Contributes to TGF-β-Induced MiRNA-181b Expression to Promote Gastric Cancer Metastasis by Targeting Timp3.
    Zhou Q; Zheng X; Chen L; Xu B; Yang X; Jiang J; Wu C
    Cell Physiol Biochem; 2016; 39(2):453-66. PubMed ID: 27383203
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Methylation of TIMP3 in esophageal squamous cell carcinoma.
    Smith E; De Young NJ; Tian ZQ; Caruso M; Ruszkiewicz AR; Liu JF; Jamieson GG; Drew PA
    World J Gastroenterol; 2008 Jan; 14(2):203-10. PubMed ID: 18186556
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lymphangiogenesis and Lymph Node Metastasis in Oral Squamous Cell Carcinoma.
    Arimoto S; Hasegawa T; Takeda D; Saito I; Amano R; Akashi M; Komori T
    Anticancer Res; 2018 Nov; 38(11):6157-6162. PubMed ID: 30396932
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IL-32 gamma reduces lung tumor development through upregulation of TIMP-3 overexpression and hypomethylation.
    Yun J; Park MH; Son DJ; Nam KT; Moon DB; Ju JH; Hwang OK; Choi JS; Kim TH; Jung YS; Hwang DY; Han SB; Yoon DY; Hong JT
    Cell Death Dis; 2018 Feb; 9(3):306. PubMed ID: 29467412
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sp1 promotes cell migration and invasion in oral squamous cell carcinoma by upregulating Annexin A2 transcription.
    Liu XB; Wang J; Li K; Fan XN
    Mol Cell Probes; 2019 Aug; 46():101417. PubMed ID: 31254619
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tissue inhibitor of metalloproteinase-3 (TIMP3) expression decreases during melanoma progression and inhibits melanoma cell migration.
    Das AM; Bolkestein M; van der Klok T; Oude Ophuis CM; Vermeulen CE; Rens JA; Dinjens WN; Atmodimedjo PN; Verhoef C; Koljenović S; Smits R; Ten Hagen TL; Eggermont AM
    Eur J Cancer; 2016 Oct; 66():34-46. PubMed ID: 27522248
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of matrix metalloproteinases (MMP-1 and -2) and their inhibitors (TIMP-1, -2 and -3) in oral lichen planus, dysplasia, squamous cell carcinoma and lymph node metastasis.
    Sutinen M; Kainulainen T; Hurskainen T; Vesterlund E; Alexander JP; Overall CM; Sorsa T; Salo T
    Br J Cancer; 1998 Jun; 77(12):2239-45. PubMed ID: 9649139
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alterations of the tissue inhibitor of metalloproteinase-3 (TIMP3) gene in pancreatic adenocarcinomas.
    Fendrich V; Slater EP; Heinmöller E; Ramaswamy A; Celik I; Nowak O; Chaloupka B; Gerdes B; Bartsch DK
    Pancreas; 2005 Mar; 30(2):e40-5. PubMed ID: 15714128
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Promoter hypermethylation contributes to TIMP3 down-regulation in high stage endometrioid endometrial carcinomas.
    Catasus L; Pons C; Muñoz J; Espinosa I; Prat J
    Histopathology; 2013 Mar; 62(4):632-41. PubMed ID: 23379820
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Site-specific DNA methylation in the neurofibromatosis (NF1) promoter interferes with binding of CREB and SP1 transcription factors.
    Mancini DN; Singh SM; Archer TK; Rodenhiser DI
    Oncogene; 1999 Jul; 18(28):4108-19. PubMed ID: 10435592
    [TBL] [Abstract][Full Text] [Related]  

  • 34. DNA hypermethylation of TIMP3 gene in invasive breast ductal carcinoma.
    Lui EL; Loo WT; Zhu L; Cheung MN; Chow LW
    Biomed Pharmacother; 2005 Oct; 59 Suppl 2():S363-5. PubMed ID: 16507410
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The promoter activity of human Mfn2 depends on Sp1 in vascular smooth muscle cells.
    Sorianello E; Soriano FX; Fernández-Pascual S; Sancho A; Naon D; Vila-Caballer M; González-Navarro H; Portugal J; Andrés V; Palacín M; Zorzano A
    Cardiovasc Res; 2012 Apr; 94(1):38-47. PubMed ID: 22253285
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Down-regulation and promoter methylation of tissue inhibitor of metalloproteinase 3 in choriocarcinoma.
    Feng H; Cheung AN; Xue WC; Wang Y; Wang X; Fu S; Wang Q; Ngan HY; Tsao SW
    Gynecol Oncol; 2004 Aug; 94(2):375-82. PubMed ID: 15297175
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CD47-SIRPα Signaling Induces Epithelial-Mesenchymal Transition and Cancer Stemness and Links to a Poor Prognosis in Patients with Oral Squamous Cell Carcinoma.
    Pai S; Bamodu OA; Lin YK; Lin CS; Chu PY; Chien MH; Wang LS; Hsiao M; Yeh CT; Tsai JT
    Cells; 2019 Dec; 8(12):. PubMed ID: 31861233
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Promoter methylation of TIMP3 and CDH1 predicts better outcome in head and neck squamous cell carcinoma treated by radiotherapy only.
    De Schutter H; Geeraerts H; Verbeken E; Nuyts S
    Oncol Rep; 2009 Feb; 21(2):507-13. PubMed ID: 19148529
    [TBL] [Abstract][Full Text] [Related]  

  • 39. DNA methylation in patients with colorectal cancer--correlation with some clinical and morphological features and with local tumour invasion.
    Mirchev MB; Kahl P; Friedrichs N; Kotzev IA; Buettner R
    Folia Med (Plovdiv); 2010; 52(2):22-30. PubMed ID: 20836393
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Loss of expression of TIMP3 in clear cell renal cell carcinoma.
    Masson D; Rioux-Leclercq N; Fergelot P; Jouan F; Mottier S; Théoleyre S; Bach-Ngohou K; Patard JJ; Denis MG
    Eur J Cancer; 2010 May; 46(8):1430-7. PubMed ID: 20194016
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.